India Biotech Revenues Grow By 20 Percent, Under Usual 30 Percent
This article was originally published in PharmAsia News
India's biotechnology industry grew by 20 percent during 2007-2008, registering $2.56 billion in revenues. But BioSpectrum, which commissioned the biotech survey, said the appreciation of the Indian rupee and pricing pressures on exports, which account for more than half the sector's revenues, meant the one-year growth was short of the 30 percent annual growth the industry had registered for five consecutive years. A spokesman for BioSpectrum said, however, the current growth trend for the Indian industry bodes well for registering $13 billion to $16 billion in revenues by 2015. (Click here for more
You may also be interested in...
Results from two trials confirm patients at high risk of bleeding treated with Abbott’s Xience stent can be safely treated with short regimens of dual antiplatelet therapy.
Through a licensing-out deal with ORIC for its EGFR/HER2 exon-20 inhibitor, South Korea's Voronoi hopes to gain from its new partner's commercialization experience in NSCLC. The alliance hopes to build a potentially best-in-class presence in a competitive landscape.
An expert panel at the virtual HLTH conference discussed the role of robotics in improving health and wellness in the health continuum. See what Darla Hutton, vice president of US marketing and customer hospital analytics at Intuitive Surgical, said about the future of robotics.